Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      MetaVia Reports Third Quarter 2026 Financial Results and Provides Corporate Update
      Biotech

      MetaVia Reports Third Quarter 2026 Financial Results and Provides Corporate Update

      November 13, 2026
      Inhibrx Reports Third Quarter 2026 Financial Results
      Biotech

      Inhibrx Reports Third Quarter 2026 Financial Results

      November 13, 2026
      Lilly breaks ground in Pennsylvania’s Lehigh Valley on a $3.5 billion site to make next-generation obesity medicines, the latest of 10 new U.S. sites since 2020
      Biotech

      Lilly breaks ground in Pennsylvania’s Lehigh Valley on a $3.5 billion site to make next-generation obesity medicines, the latest of 10 new U.S. sites since 2020

      November 13, 2026
      Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2026 Financial Results
      Biotech

      Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2026 Financial Results

      November 13, 2026
      Curis Provides Third Quarter 2026 Business Update
      Biotech

      Curis Provides Third Quarter 2026 Business Update

      November 13, 2026
      Armata Pharmaceuticals Announces Financial Results for the Third Quarter 2026 and Provides Corporate Update
      Biotech

      Armata Pharmaceuticals Announces Financial Results for the Third Quarter 2026 and Provides Corporate Update

      November 13, 2026
      Atrium Therapeutics Reports Third Quarter 2026 Financial Results
      Biotech

      Atrium Therapeutics Reports Third Quarter 2026 Financial Results

      November 13, 2026
      VolitionRx Limited Announces Third Quarter 2026 Financial Results and Business Update
      Biotech

      VolitionRx Limited Announces Third Quarter 2026 Financial Results and Business Update

      November 12, 2026
      Nektar Therapeutics Announces Third Quarter 2026 Financial Results
      Biotech

      Nektar Therapeutics Announces Third Quarter 2026 Financial Results

      November 12, 2026
      Reviva Reports Third Quarter 2026 Financial Results and Recent Business Highlights
      Biotech

      Reviva Reports Third Quarter 2026 Financial Results and Recent Business Highlights

      November 12, 2026
      « 1 … 4 5 6 7 8 … 176 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026